Acorah Software Products - Accounts Production 15.0.400 false true false true No description of principal activity 1 May 2022 30 April 2023 30 April 2023 14047409 Mr Anthony Kays iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14047409 2022-04-30 14047409 2023-04-30 14047409 2022-05-01 2023-04-30 14047409 frs-core:CurrentFinancialInstruments 2023-04-30 14047409 frs-bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 14047409 frs-bus:FilletedAccounts 2022-05-01 2023-04-30 14047409 frs-bus:Micro-entities 2022-05-01 2023-04-30 14047409 frs-bus:AuditExempt-NoAccountantsReport 2022-05-01 2023-04-30 14047409 frs-bus:Director1 2022-05-01 2023-04-30
Registered number: 14047409
Ricall Healthcare Limited
Unaudited Financial Statements
For The Year Ended 30 April 2023
Balance Sheet
Registered number: 14047409
2023
£
Fixed assets 262
Current assets 5,085
Creditors: Amounts Falling Due Within One Year (4,851 )
NET CURRENT ASSETS 234
TOTAL ASSETS LESS CURRENT LIABILITIES 496
NET ASSETS 496
CAPITAL AND RESERVES 496

Notes

1. General Information
Ricall Healthcare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14047409 . The registered office is 38 Dulverton Grove, Leeds, LS11 0LD.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Anthony Kays
Director
20/06/2024